Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.24.2.u1
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Share-Based Compensation Expense The following table sets forth share-based compensation expense included in the condensed consolidated statements of operations:
Three Months Ended June 30,
(in thousands)
2024
2023
Cost of revenue $ 29  $ 27 
Research and development 406  370 
Sales and marketing 524  484 
General and administrative 837  764 
Share-based compensation expense $ 1,796  $ 1,645 
Six Months Ended June 30,
(in thousands)
2024
2023
Cost of revenue $ 51  $ 47 
Research and development 743  652 
Sales and marketing 945  847 
General and administrative 1,561  1,406 
Share-based compensation expense $ 3,300  $ 2,952 

Share-based compensation expense by type of share-based award is summarized below:
Three Months Ended June 30,
(in thousands)
2024
2023
Stock options $ 195  $ 266 
RSAs and RSUs 1,540  1,312 
ESPP 61  67 
$ 1,796  $ 1,645 
Six Months Ended June 30,
(in thousands)
2024
2023
Stock options $ 403  $ 514 
RSAs and RSUs 2,776  2,304 
ESPP 121  134 
$ 3,300  $ 2,952 
Total unrecognized compensation expense by type of award and the weighted-average remaining requisite holding period over which such expense is expected to be recognized (in thousands, unless otherwise noted):
June 30, 2024
Unrecognized Expense Remaining Weighted-Average Recognition Period (in years)
Stock options $ 597  1.31
RSAs and RSUs $ 11,310  2.03
Schedule of Stock Option Activity
Stock option activity under the Company’s current and previous plans during the six months ended June 30, 2024 is summarized below:
Stock Options Weighted-average
Exercise price
per share		 Weighted-average
Remaining Contractual Life (in years)
Intrinsic
Value(1)
(in thousands)
Outstanding at December 31, 2023 1,478,157  $ 8.40 
Exercised (11,000) $ 3.01 
Forfeited or expired (6,112) $ 42.82 
Outstanding at June 30, 2024 1,461,045  $ 8.30  4.99 $ 2,183 
Exercisable at June 30, 2024 1,302,175  $ 8.03  4.60 $ 2,183 
Vested and expected to vest at June 30, 2024 1,461,045  $ 8.30  4.99 $ 2,183 
(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Schedule of Restricted Stock Activity
Restricted stock award ("RSA") activity for the six months ended June 30, 2024 is summarized below:
Restricted Stock Awards Weighted - Average
Grant
Date Fair Value
Outstanding at December 31, 2023 376,914  $ 12.02 
Vested (147,197) $ 11.76 
Forfeited (3,679) $ 12.11 
Outstanding at June 30, 2024 226,038  $ 12.18 
Restricted Stock Unit Activity
Restricted stock unit ("RSU") activity for the six months ended June 30, 2024 is summarized below:
Restricted Stock Units Weighted - Average
Grant
Date Fair Value
Outstanding at December 31, 2023 768,139  $ 8.15 
Granted 1,192,622  $ 6.16 
Vested (260,441) $ 8.06 
Forfeited (12,911) 8.52 
Outstanding at June 30, 2024 1,687,409  $ 6.76